NEWS

Latest

Nordex shares “only” stable despite order news – what’s next?

This morning, the wind power plant manufacturer Nordex presented the first key data for 2020. After having been able to…

Read More »
Latest

BioNTech: A lot of good news

There has been tremendous progress with BioNTech and Pfizer’s corona vaccination. Until now, the necessary storage at -70 degrees was…

Read More »
Latest

Plug Power share: News from the “casino” – exciting Monday ahead!

Our warning of possible significant profit-taking from the Plug Power share came at the right time. On the Wednesday before…

Read More »
Economy & Politics

Podcast learning platform Simpleclub: “We were flooded with news”

The need for learning platforms and online offers for schoolchildren has increased due to the corona pandemicimago images / MiS…

Read More »
Latest

Bayer: Good news from the USA

Bayer can report good news from the USA for the drug candidate Finerenone: the FDA has granted the application priority…

Read More »
Latest

Inflarx share: there is good news and buy signals on top – chart analysis

Yesterday there was not only news from Inflarx, but also a price jump including a new technical buy signal for…

Read More »
Cryptocurrencies

Block-Note, the condensed news not to be missed! – Cryptocurrencies

Block-Note is an initiative launched by Hasheur in 2018. Once every two weeks, Hasheur and a guest from the ecosystem…

Read More »
Latest

Abivax share with price jump: News from Evotec partner on COVID-19 drug ABX464

At Euronext Paris, the Abivax share gains significantly today. The share price of the biotech company is currently up around…

Read More »
Latest

K + S: Equity experts skeptical, news from the Werra works

K + S has received a new water law permit from the authorities for the Werra and Neuhof-Ellers plants from…

Read More »
Latest

Compleo: News from the group of shareholders

Compleo major shareholder Fontus Invest is dissolved. The company, through which Compleos Co-CEO and CFO Georg Griesemann and COO Jens…

Read More »
Back to top button
Close
Close